AGEFI [FR] | De nombreuses entreprises suisses développent l’intelligence artificielle (FR)
Machine-learning and eye medicine
Based in Berne, the start-up RetinAI Medical aims to support professionals eye care and patients throughout the medical examination process using artificial intelligence. "Our vision is to promote the transition from reactive to preventive medicine for high-impact diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma," says co-founder Carlos Ciller. Launched in December 2016 in Berne, the company is expanding and already extending to the United States.
"Our solutions are based on the latest advances in medical image analysis, ophthalmology and machine learning. We program the machines so that they can automatically detect the different pathologies ocular, "he adds." The IA will make it possible to simplify the field of ophthalmology by facilitating access to care, allowing to reduce costs and accelerating medical diagnostic.